STEMPOINT CAPITAL LP
Filing Date
Global Rank
#2,319
/ 8,622
▲ 113
· as of Mar 2026
Top Industry
Biotechnology
92.0%
3Y Alpha vs SPY
-5.1%
Period ended 4 months ago
Filed May 18, 2026 · 2mo
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+37.1%
SPY
+52.7%
Annualised alpha
-5.1%
Max drawdown
−46.1%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 91% of reported value on average across 10 quarters. Past performance does not predict future results.
Portfolio Concentration
75 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.9%
−0.0 pts
Top 5
30.8%
−0.9 pts
Top 10
45.7%
−1.7 pts
HHI
317
Diversified−23
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 90.6% | $565,958,783 |
| Unclassified | 8.9% | $55,604,200 |
| Financial Services | 0.5% | $3,099,084 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
21 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | +884,724 | 1,874,546 | $2,436,909 | |
| EYPT | EyePoint, Inc. | +456,915 | 810,764 | $10,450,747 | |
| MBX | MBX Biosciences, Inc. | +420,916 | 499,469 | $14,909,149 | |
| RVMD | Revolution Medicines, Inc. | +319,600 | 381,632 | $37,113,712 | |
| MLYS | Mineralys Therapeutics, Inc. | +243,329 | 533,378 | $14,449,210 | |
| SABS | SAB Biotherapeutics, Inc. | +228,442 | 375,000 | $1,436,250 | |
| IMVT | Immunovant, Inc. | +201,535 | 846,494 | $21,026,910 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +189,052 | 413,792 | $9,748,939 | |
| SYRE | Spyre Therapeutics, Inc. | +135,229 | 167,606 | $8,454,046 | |
| EVMN | Evommune, Inc. | +125,581 | 193,777 | $4,454,933 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +107,552 | 180,658 | $5,782,862 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +104,545 | 669,685 | $9,308,621 | |
| PRAX | Praxis Precision Medicines, Inc. | +35,200 | 56,267 | $18,128,664 | |
| QURE | uniQure N.V. | +34,581 | 78,066 | $1,276,379 | |
| ASMB | Assembly Biosciences, Inc. | +28,707 | 185,435 | $5,145,821 | |
| PHVS | Pharvaris N.V. | +28,248 | 86,637 | $2,447,495 | |
| SNDX | Syndax Pharmaceuticals Inc | +26,364 | 1,365,743 | $31,903,756 | |
| CAPR | Capricor Therapeutics, Inc. | +19,739 | 37,592 | $1,142,796 | |
| PTGX | Protagonist Therapeutics, Inc | +13,147 | 72,577 | $7,649,615 | |
| DNLI | Denali Therapeutics Inc. | +7,503 | 426,561 | $8,189,971 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +6,218 | 85,502 | $7,175,327 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | −580,898 | 385,800 | $10,686,660 | |
| WHWK | Whitehawk Therapeutics, Inc. | −519,438 | 939,369 | $3,240,823 | |
| TWST | Twist Bioscience Corp | −475,245 | 43,110 | $2,048,587 | |
| TERN | Terns Pharmaceuticals, Inc. | −329,198 | 100,000 | $5,272,000 | |
| DYN | Dyne Therapeutics, Inc. | −329,125 | 506,075 | $9,175,139 | |
| XENE | Xenon Pharmaceuticals Inc. | −207,850 | 140,755 | $8,184,903 | |
| GPCR | Structure Therapeutics Inc. | −150,806 | 200,267 | $9,652,869 | |
| SRZN | Surrozen, Inc./DE | −94,127 | 525,639 | $15,311,863 | |
| ABVX | Abivax S.A. | −77,992 | 313,791 | $34,940,627 | |
| EWTX | Edgewise Therapeutics, Inc. | −70,012 | 290,864 | $9,162,216 | |
| CELC | Celcuity Inc. | −58,271 | 60,062 | $6,855,476 | |
| XFOR | X4 Pharmaceuticals, Inc | −47,723 | 850,742 | $3,513,564 | |
| SRRK | Scholar Rock Holding Corp | −28,397 | 1,135,496 | $55,820,983 | |
| JNJ | Johnson & Johnson | −19,585 | 15,415 | $3,768,042 | |
| CYTK | Cytokinetics Inc | −17,401 | 129,577 | $8,540,420 | |
| AVTX | Avalo Therapeutics, Inc. | −810 | 134,742 | $2,011,698 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPY | Spdr S&P 500 ETF Trust | 50,000 | $32,517,000 | |
| QQQ | Invesco Qqq Trust, Series 1 | 40,000 | $23,087,200 | |
| BSX | Boston Scientific Corp | 250,000 | $15,687,500 | |
| ELVN | Enliven Therapeutics, Inc. | 363,438 | $14,246,769 | |
| CGON | CG Oncology, Inc. | 205,622 | $13,916,496 | |
| BHVN | Biohaven Ltd. | 1,594,491 | $13,489,393 | |
| TYRA | Tyra Biosciences, Inc. | 293,177 | $11,228,679 | |
| CLDX | Celldex Therapeutics, Inc. | 254,267 | $8,065,349 | |
| DFTX | Definium Therapeutics, Inc. | 325,483 | $6,151,628 | |
| BIOA | BioAge Labs, Inc. | 338,654 | $5,923,058 | |
| ACAD | Acadia Pharmaceuticals Inc | 242,566 | $5,399,519 | |
| ALMS | Alumis Inc. | 229,566 | $5,057,338 | |
| NRIX | Nurix Therapeutics, Inc. | 315,226 | $4,886,003 | |
| ZURA | Zura Bio Ltd | 753,520 | $4,483,444 | |
| TNGX | Tango Therapeutics, Inc. | 200,919 | $4,203,225 | |
| FTH | Faeth Therapeutics, Inc. | 132,873 | $4,188,156 | |
| RLMD | Relmada Therapeutics, Inc. | 597,409 | $4,157,966 | |
| ERAS | Erasca, Inc. | 239,861 | $3,880,950 | |
| PCVX | Vaxcyte, Inc. | 59,061 | $3,432,034 | |
| HLXC | Helix Acquisition Corp. III | 305,028 | $3,099,084 | |
| TENX | Tenax Therapeutics, Inc. | 188,700 | $3,017,313 | |
| ALKS | Alkermes plc. | 80,492 | $2,846,197 | |
| JBIO | Jade Biosciences, Inc. | 154,034 | $2,164,177 | |
| IONS | Ionis Pharmaceuticals Inc | 26,385 | $1,981,249 | |
| EW | Edwards Lifesciences Corp | 24,588 | $1,969,007 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 1,229,114 | $30,740,141 | |
| ACLX | Arcellx, Inc. | 332,860 | $21,702,472 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 17,736 | $10,328,382 | |
| PALI | Palisade Bio, Inc. | 4,192,375 | $9,852,081 | |
| DRUG | Bright Minds Biosciences Inc. | 97,340 | $7,596,413 | |
| NKTR | Nektar Therapeutics | 178,274 | $7,537,424 | |
| CLPT | ClearPoint Neuro, Inc. | 481,858 | $6,591,817 | |
| IMTX | Immatics N.V. | 610,308 | $6,408,234 | |
| OCUL | Ocular Therapeutix, Inc | 522,693 | $6,345,493 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 58,915 | $6,306,261 | |
| APGE | Apogee Therapeutics, Inc. | 80,574 | $6,081,725 | |
| INCY | Incyte Corp | 61,435 | $6,067,934 | |
| IDYA | IDEAYA Biosciences, Inc. | 161,659 | $5,588,551 | |
| MAZE | Maze Therapeutics, Inc. | 125,877 | $5,215,084 | |
| LLY | ELI LILLY & Co | 4,759 | $5,114,402 | |
| TRVI | Trevi Therapeutics, Inc. | 399,557 | $5,002,453 | |
| VRDN | Viridian Therapeutics, Inc.\DE | 154,320 | $4,802,438 | |
| ABUS | Arbutus Biopharma Corp | 986,751 | $4,746,272 | |
| MLTX | MoonLake Immunotherapeutics | 348,401 | $4,591,925 | |
| CTMX | CytomX Therapeutics, Inc. | 1,036,311 | $4,414,684 | |
| ASND | Ascendis Pharma A/S | 14,842 | $3,164,908 | |
| RGEN | Repligen Corp | 15,707 | $2,573,749 | |
| QNCX | Quince Therapeutics, Inc. | 739,264 | $2,476,534 | |
| ADPT | Adaptive Biotechnologies Corp | 606,825 | $2,463,709 | |
| MGTX | MeiraGTx Holdings plc | 287,689 | $2,287,127 | |
| No positions match the current search. | ||||
75 tracked positions ·
$624,662,067 total
· as of Mar 31, 2026
Showing 1–50
of 75 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
CALL
+ SHARES
Healthcare
|
Reduced | 1,135,496 | $55,820,983 | 8.94% | |
| RVMD |
Revolution Medicines, Inc.
PUT
+ SHARES
Healthcare
|
Added | 381,632 | $37,113,712 | 5.94% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 313,791 | $34,940,627 | 5.59% | |
| SPY |
Spdr S&P 500 ETF Trust
CALL
|
NEW | 50,000 | $32,517,000 | 5.21% | |
| SNDX |
Syndax Pharmaceuticals Inc
CALL
+ SHARES
Healthcare
|
Added | 1,365,743 | $31,903,756 | 5.11% | |
| QQQ |
Invesco Qqq Trust, Series 1
CALL
|
NEW | 40,000 | $23,087,200 | 3.70% | |
| IMVT |
Immunovant, Inc.
CALL
+ SHARES
Healthcare
|
Added | 846,494 | $21,026,910 | 3.37% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 56,267 | $18,128,664 | 2.90% | |
| BSX |
Boston Scientific Corp
CALL
Healthcare
|
NEW | 250,000 | $15,687,500 | 2.51% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 525,639 | $15,311,863 | 2.45% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 499,469 | $14,909,149 | 2.39% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 533,378 | $14,449,210 | 2.31% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 363,438 | $14,246,769 | 2.28% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
NEW | 205,622 | $13,916,496 | 2.23% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 1,594,491 | $13,489,393 | 2.16% | |
| TYRA |
Tyra Biosciences, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 293,177 | $11,228,679 | 1.80% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 385,800 | $10,686,660 | 1.71% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 810,764 | $10,450,747 | 1.67% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 413,792 | $9,748,939 | 1.56% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 200,267 | $9,652,869 | 1.55% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 669,685 | $9,308,621 | 1.49% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 506,075 | $9,175,139 | 1.47% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 290,864 | $9,162,216 | 1.47% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 129,577 | $8,540,420 | 1.37% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Added | 167,606 | $8,454,046 | 1.35% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 426,561 | $8,189,971 | 1.31% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 140,755 | $8,184,903 | 1.31% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 254,267 | $8,065,349 | 1.29% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 72,577 | $7,649,615 | 1.22% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 85,502 | $7,175,327 | 1.15% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 60,062 | $6,855,476 | 1.10% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 325,483 | $6,151,628 | 0.98% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 338,654 | $5,923,058 | 0.95% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 180,658 | $5,782,862 | 0.93% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
NEW | 242,566 | $5,399,519 | 0.86% | |
| TERN |
Terns Pharmaceuticals, Inc.
CALL
Healthcare
|
Reduced | 100,000 | $5,272,000 | 0.84% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 185,435 | $5,145,821 | 0.82% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 229,566 | $5,057,338 | 0.81% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 315,226 | $4,886,003 | 0.78% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
NEW | 753,520 | $4,483,444 | 0.72% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 193,777 | $4,454,933 | 0.71% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 200,919 | $4,203,225 | 0.67% | |
| FTH |
Faeth Therapeutics, Inc.
Healthcare
|
NEW | 132,873 | $4,188,156 | 0.67% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 597,409 | $4,157,966 | 0.67% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 239,861 | $3,880,950 | 0.62% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 15,415 | $3,768,042 | 0.60% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 850,742 | $3,513,564 | 0.56% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 59,061 | $3,432,034 | 0.55% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Reduced | 939,369 | $3,240,823 | 0.52% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
NEW | 305,028 | $3,099,084 | 0.50% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.